LungLife AI is transforming cancer diagnosis and management through AI-enabled molecular analysis of cancer biomarkers in blood.
Joined May 2019
- Tweets153
- Following13
- Followers72
- Likes79
Our LungLB test is a game-changer in lung cancer detection! 🌟 With rising lung cancer rates in never-smokers, we are committed to addressing this need. Early detection for everyone, everywhere. 💙
#LungLifeAI #LungLB #EarlyDetection #LungCancerAwareness #HealthInnovation
Getting tested for lung cancer has never been easier! Join us in making early detection accessible and convenient. 🩸💙
#EarlyDetection #LungCancerAwareness #HealthInnovation
LungLife AI is at the forefront of revolutionizing early lung cancer detection with cutting-edge technology. Early detection saves lives—spread the word and support innovative solutions! 💙
#LungLifeAI #EarlyDetection #LungCancerAwareness #HealthInnovation
Our CEO Paul Pagano recently spoke with @Medtech_Insight, providing an overview of our LungLB test and the need for early lung cancer detection, as well as our journey towards reimbursement.
Listen to the episode here: soundcloud.com/citelinesound…
Delighted to have our CEO, Paul Pagano present at the recent Early Detection Research Network conference; and even more delighted that our test is receiving recognition by such a prestigious body.
edrn.nci.nih.gov/about-edrn/…
#LLAI
LungLife AI retweeted
LungLife AI (AIM: #LLAI, @LungLifeAI) Notice of AGM
📅4:00 P.M. (BST) on 5 June 2024
📪Annual Report & Accounts posted to shareholders
🔗londonstockexchange.com/news…
LungLife has been invited to present at @theNCI Early Detection Research Network (#EDRN) meeting in Tempe, Arizona today.
Read the full announcement including details of the presentation here: lunglifeai.com/news/
LungLife AI retweeted
Fantastic to see Walbrook clients @LungLifeAI (AIM: #LLAI) and @GenIncode (AIM: #GENI) covered in @SHARESmag's recent article 'Invest in the Future of Medicine', covering some of the most innovative companies working in AI, robotics and genetics.
sharesmagazine.co.uk/article…
Great to be highlighted in @SHARESmag's recent feature 'Invest in the Future of Medicine', covering some of the most innovative technology companies in medicine.
Read the piece below (behind paywall) sharesmagazine.co.uk/article…
#LLAI
LungLife AI retweeted
Q&A with Lunglife AI CEO, Paul Pagano
#AIM #LLAI @LungLifeAI #clinicaldiagnostics #lungcancer
Watch the Q&A here: voxmarkets.co.uk/articles/q-…
#investing #shares #voxmarkets via @VOXmarkets
*WATCH* the latest investor presentation with LungLife CEO, Paul Pagano and CFO David Anderson following the Company's full year results for 2023.
youtu.be/x1NaLOiAr-o
#LLAI
LungLife AI announces its audited preliminary results for the year ended 31 December 2023.
Read the full announcement here:
londonstockexchange.com/stoc…
#LLAI
LungLife AI retweeted
LungLife AI (AIM: #LLAI, @LungLifeAI) FY Results
Highlights
💷Cash of $2.83m
✅LungLB PLA code 0317U added
📚Multi-site validation of LungLB published
⭐️Successful clinical validation of LungLB test - PPV 81%
💰Fundraise of $2.28m
🔗londonstockexchange.com/news…
LungLife AI retweeted
.@Investec has reiterated its Buy rating for @LungLifeAI following today's FY results.
⭐️ Recent validation data and expected Medicare coverage highlight commercial opportunity for LungLB®
🛣️ Early licensing/partnering strategy set up near-term catalysts
🎯 TP: 229p (CP: 30p)
LungLife AI (AIM: #LLAI, @LungLifeAI) FY Results
Highlights
💷Cash of $2.83m
✅LungLB PLA code 0317U added
📚Multi-site validation of LungLB published
⭐️Successful clinical validation of LungLB test - PPV 81%
💰Fundraise of $2.28m
🔗londonstockexchange.com/news…
LungLife AI retweeted
LungLife AI: Unlocking value in lung cancer diagnostics
#AIM #LLAI @LungLifeAI @CapitalPmh #AI #diagnostics
Read the article here: voxmarkets.co.uk/articles/lu…
#investing #shares #voxmarkets via @VOXmarkets
LungLife will announce its full year results on Thursday 4 April 2024.
Paul Pagano, CEO, and David Anderson, CFO, will be hosting a presentation via the @InvestorMeetCo platform at 4.00pm (BST) on Friday 5 April 2024.
investormeetcompany.com/lung…
*WATCH* LungLife AI CEO, Paul Pagano as he discusses the successful validation of the Company's LungLB test with @proactive_UK
#LLAI
$LLAI LungLife AI announces success in Validation of LungLB in multi-site, prospective clinical study tinyurl.com/yulxblxu @lunglifeai #LLAI
We are pleased to announce the successful validation of the LungLB® test for indeterminate lung nodules from a prospective, multi-site clinical study in the clinically important small nodules patient group.
Read the full announcement here:
lunglifeai.com/successful-va…
#LLAI
LungLife AI retweeted
$LLAI LungLife AI shares jump 43% after validation of cancer diagnostic tinyurl.com/ysrn3lfs @lunglifeai #LLAI
LungLife AI retweeted
LungLife AI shares soar after successful validation of lung cancer test
@LungLifeAI #LLAI #AIM #diagnostics
Read more here: voxmarkets.co.uk/articles/lu…